Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Medical Service Q3 Earnings Slated On Nov 3: AMN, AIRM, MEDP

Published 11/01/2016, 09:16 PM
Updated 07/09/2023, 06:31 AM

The Q3 earnings season is in full swing right now. As per the latest Earnings Outlook, 332 S&P companies have already disclosed their numbers as of Nov 1. Notably, reported earnings increased 1.9% year over year on a 1.3% rise in revenues, with the beat ratio being 72.9% for earnings and 55.4% for revenues.

The current week is witnessing a plethora of earnings releases as many bigwigs are lined up to report their quarterly numbers. Notably, the third-quarter earnings season is projected to be the first to see positive earnings growth after five consecutive quarters of decline, courtesy of improving growth trends, a string of positive surprises and stability in current-quarter estimates.

Medical is one of the major broader sectors among the 16 Zacks sectors in the S&P 500 cohort expected to report earnings growth in the third quarter. The sector is likely to report earnings growth of 6% on revenue improvement of 7.3%.

Medical service, as defined by Zacks, is a niche area under the medical device subcategory within the broader Medical sector. Accordingly, it holds more promise right now. Currently, the medical services space is ranked the 81st best industry out of the 265 industries covered by Zacks.

Here, we take a sneak peek into three medical services stock stocks set to report their third-quarter figures on Nov 3:

AMN Healthcare Services, Inc. (NYSE:AMN) provides healthcare workforce solutions and staffing services in the United States. It delivers managed services programs, healthcare executive search solutions, vendor management systems, recruitment process outsourcing, predictive modeling, medical coding and consulting, and other services. Last quarter, this company beat the estimate by 17.31%. AMN Healthcare has an Earnings ESP of +1.79% as the Most Accurate estimate stands at 57 cents per share, which is higher than the Zacks Consensus Estimate of 56 cents. Thus, the company is likely to beat on earnings, given the combination of a positive ESP and a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here .

With respect to the surprise trend, AMN Healthcare surpassed expectations in each of the last four quarters, with an average beat of 21.25%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

AMN HLTHCR SVCS Price and EPS Surprise

AMN HLTHCR SVCS Price and EPS Surprise | AMN HLTHCR SVCS Quote

Air Methods Corporation (NASDAQ:AIRM) is an American publicly owned helicopter operator. Its Domestic Air Medical Division provides emergency medical services to 100,000 patients every year, and serves 48 states and Haiti. Last quarter, this company missed the estimate by 6.67%. Air Methods has an Earnings ESP of -1.96% as the Most Accurate estimate stands at $1.00 per share, lower than the Zacks Consensus Estimate of $1.02 per share. The company carries a Zacks Rank #4 (Sell), which lowers the predictive power of ESP. Please check our Earnings ESP Filter that enables you to find stocks that are expected to come out with earnings surprises.

With respect to the surprise trend, Air Methods surpassed expectations in three of the last four quarters, with the average beat being 9.22%.

AIR METHODS CRP Price and EPS Surprise

AIR METHODS CRP Price and EPS Surprise | AIR METHODS CRP Quote

Medpace Holdings, Inc. (NASDAQ:MEDP) is a full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. However, our proven model does not conclusively show that the company is likely to beat on earnings, given the combination of an Earnings ESP of 0.00% – as both the Zacks Consensus Estimate and the Most Accurate estimate are pegged at 34 cents – and a Zacks Rank #3.

MEDPACE HLDGS Price and EPS Surprise

MEDPACE HLDGS Price and EPS Surprise | MEDPACE HLDGS Quote

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Looking for Ideas with Even Greater Upside?

Today's investment ideas are short-term, directly based on our proven 1 to 3 month indicator. In addition, I invite you to consider our long-term opportunities. These rare trades look to start fast with strong Zacks Ranks, but carry through with double and triple-digit profit potential. Starting now, you can look inside our home run, value, and stocks under $10 portfolios, plus more. Click here for a peek at this private information >>



AMN HLTHCR SVCS (AMN): Free Stock Analysis Report

AIR METHODS CRP (AIRM): Free Stock Analysis Report

MEDPACE HLDGS (MEDP): Free Stock Analysis Report

Original post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.